In one of our key studies, we used the NextBio search engine to interpret the gene expression changes between adenoma tumors associated with two distinct genotypes
CUPERTINO, Calif. (PRWEB) February 4, 2008
"In one of our key studies, we used the NextBio search engine to interpret the gene expression changes between adenoma tumors associated with two distinct genotypes," said Robert Oshima, Ph.D., Tumor Development Program co-Director and Professor at the Burnham Institute. "Instead of manually evaluating hundreds of genes through literature, we were able to quickly search for conditions with similar biological changes using a combined collection of public studies. NextBio has proven to be valuable in interpreting gene expression changes in our experiments."
"The ability of Burnham scientists to utilize huge quantities of public and internal experimental data in an easy way is fundamental to our research efforts," commented Craig Hauser, Ph.D., Cancer Center Associate Director at Burnham Institute for Medical Research. "NextBio's life science search engine enables our researchers and clinicians to generate and validate new hypotheses using information from thousands of large-scale experimental studies."
"We are delighted to see the Burnham Institute provide access to NextBio for its entire research staff and believe that NextBio will become an integral part of their daily research," said Ilya Kupershmidt, NextBio's Vice President of Product Management. "We are very pleased that Burnham, as one of our pioneering customers, has renewed and expanded its license to use NextBio."
NextBio is a life science search engine that enables researchers and clinicians to access and understand the world's life sciences information to find important new correlations, make discoveries, and generate hypotheses as never before. NextBio is implemented as a "Software as a Service" (SaaS) model that permits users to use its search engine directly via the web and internal client sites through the NextBio Application Programming Interface (API). NextBio is used daily by some of the world's leading research enterprises, including Stanford University, UC Davis, Scripps Research Institute, Johnson & Johnson, Celgene and Genzyme.
NextBio is a privately held, venture-backed company that has developed the first data search engine for the life sciences community. NextBio provides instant access and search, user-generated content and collaboration to scientists and clinicians worldwide. For more information on the company, please visit our website at http://www.nextbio.com.